American Society of Clinical Oncology Plenary Session

Akeso lung cancer drug shines in trials, boosting hopes in US$20b market

AdvertisementChina’s private sectorBusinessChina Business Akeso lung cancer drug shines in trials, boosting hopes in US$20b market Ivonescimab phase three trials…